Document › Details

BIOCIUS Life Sciences, Inc.. (3/29/10). "Press Release: BIOCIUS Life Sciences Announces New Global Headquarters, Doubles Capacity. New Facility Enables further Expansion of RapidFire High-throughput Screening Products and Services". Woburn, MA.

	Region	Wakefield, MA
	Country	United States (USA)
	Organisation	Biocius Life Sciences Inc.
	Group	Agilent (Group)
	Product	RapidFire™ Mass Spectrometry system
	Product 2	RapidFire™ Lead Discovery (service)
	Person	Leathe, Jeffrey (Jeff) (BIOCIUS 200912– before BioTrove before Pelican Life Sciences CEO before Apogent CFO)

BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and lead discovery screening services.

"BIOCIUS has started on a growth trajectory and the new facility provides an environment to accommodate our expansion plans," said Jeffrey Leathe, Chairman and CEO. "The space was designed with our clients in mind - our increased capacity includes state-of-the-art facilities for demonstration and training."

Located about five miles from BIOCIUS's current facility, the new headquarters expands the manufacturing capacity and increases the company's contract research screening capabilities by 50%. An enhanced demonstration laboratory and a seminar/training room are also highlights of the new center. The open plan format of the Headquarters will further facilitate employee collaboration and represents the ideal environment for the team to address new technologies in the company's development pipeline. BIOCIUS plans to relocate to the site in June of this year.

About BIOCIUS Life Sciences

Named from the Greek word "BIO" (life) and the Latin word "OCIUS" (faster), BIOCIUS Life Sciences, provides the biopharmaceutical industry with faster answers: Products and services committed to speed and accuracy in drug discovery. Used by 13 of the top 15 pharmaceutical companies, BIOCIUS's products and contract research services enable our partners to exceed their business goals.

RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

BIOCIUS Life Sciences, Inc.. (3/29/10). "Press Release: BIOCIUS Life Sciences Announces New Global Headquarters, Doubles Capacity. New Facility Enables further Expansion of RapidFire High-throughput Screening Products and Services". Woburn, MA.

More documents for Agilent (Group)